Evidence-based·Updated November 19, 2026·How we grade evidence

Kisspeptin

PeptideResearch peptide

Kisspeptin reliably raises LH, FSH and testosterone for hours in research studies, and single doses of kisspeptin-54 have triggered egg maturation in small IVF studies at one London clinic. Short studies also found changes in brain responses to sexual cues in people with low sexual desire. All of this comes from small, supervised studies, mostly with infusions into a vein; there are no trials of the injections sold online, no long-term safety data, and no approved product.

Taking Kisspeptin with other supplements or medications?Check your whole list for interactions. Free, no account.

Research compound: not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.

Quick decision guide

May help most

Research participants in registered clinical trials; there is no approved use

Common dosing range

No approved or established dose. Studies used weight-based infusions or single injections under supervision

When to expect effects

LH rises within 30 minutes of an intravenous dose; repeated dosing can blunt the response

Watch out for

Not FDA-approved for any use; FDA lists kisspeptin-10 as a compounding substance that may present significant safety risks; repeated or continuous dosing can desensitize or even suppress the hormone system; "research" products are unverified

What is it

Kisspeptin is a natural hormone that switches on the body's reproductive hormone system by triggering the release of GnRH from the brain, which in turn raises LH, FSH and, in men, testosterone. Lab-made versions, mainly kisspeptin-54 and the short form kisspeptin-10, have been given to volunteers and patients in university research studies, usually as an infusion into a vein or as a single injection under close supervision. No kisspeptin product is approved by FDA for any use, and no approved product exists in the US to compare against. FDA has listed kisspeptin-10 in category 2 for pharmacy compounding (bulk substances that may present significant safety risks) since September 29, 2023, and it was still there in FDA's list updated May 14, 2026. Products sold online as kisspeptin-10 for "research" are unapproved, and their purity and dose are unverified.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You qualify for a registered clinical trial of kisspeptin for a reproductive condition (several are listed on ClinicalTrials.gov) and want to take part under medical supervision
You have low testosterone, infertility or low sexual desire and want to discuss approved treatments with a doctor while kisspeptin is still being studied

Probably skip if…

You would be buying kisspeptin-10 vials or sprays online: they are unapproved, unverified, and FDA lists kisspeptin-10 as a compounding substance that may present significant safety risks
You want a lasting testosterone boost: repeated or continuous dosing can blunt the response, and a continuous kisspeptin-type drug suppressed testosterone
You are trying to conceive on your own: in studies it was used only by fertility specialists with hormone and ultrasound monitoring
You are pregnant or breastfeeding: it has not been studied for use in pregnancy

Evidence at a glance

LH and testosterone levels in healthy men

Limited Evidence
Effect
LH about 3-fold higher within 30 minutes of one intravenous dose; smaller sustained rises with daily 8-hour infusions
Best fit
Healthy men in research studies
Time
Within 30 minutes; the effect fades with continuous exposure

triggering egg maturation during IVF

Limited Evidence
Effect
Egg maturation in 95% of high-risk women; live birth 45% per transfer (no standard-trigger comparison group)
Best fit
Women undergoing IVF at high risk of OHSS, within a research program
Time
Eggs collected 36 hours after the injection

brain responses to sexual cues in low sexual desire (HSDD)

Limited Evidence
Effect
Changes in brain activity on MRI; penile tumescence up to 56% more than placebo during one infusion (men)
Best fit
Research participants with HSDD
Time
During a single infusion

Evidence for 3 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

LH and testosterone levels in healthy men

Biomarker support
Limited Evidence

In healthy men, a single intravenous dose of kisspeptin-10 raised LH from 4.1 to 12.4 IU/L within 30 minutes (at 1 microgram per kg, 6 men), and a 22.5-hour infusion raised testosterone from 16.6 to 24.0 nmol/L (4 men). In a 2026 randomized, single-blind, placebo-controlled study in 15 healthy men, infusions under the skin raised LH, FSH and testosterone; with a continuous 5-day infusion, testosterone stayed higher but LH and FSH fell back to placebo levels, while daily 8-hour infusions kept LH higher for 12 days (mean LH rise +1.68 on day 1 and +1.14 on day 12, versus -0.16 on vehicle; 12 men served as controls). These are hormone levels in healthy volunteers using pumps in research units. Men with low testosterone, symptoms, and the injections sold online were not studied in these trials.

Effect size
LH about 3-fold higher within 30 minutes of one intravenous dose; smaller sustained rises with daily 8-hour infusions
Time to effect
Within 30 minutes; the effect fades with continuous exposure
Best fit
Healthy men in research studies
Less likely
Men using unsupervised injections, or expecting symptom relief; continuous exposure blunted the response

Bottom line: It raises reproductive hormones for hours in healthy men, but only with careful timing, and no symptom benefit has been tested.

triggering egg maturation during IVF

Disease adjunct
Limited Evidence

At one London IVF clinic, a single injection of kisspeptin-54 under the skin was used instead of the usual trigger shot. In 53 women with subfertility, eggs matured at every dose tested, embryos were transferred in 92%, and the clinical pregnancy rate was 23% (12 of 53). In a phase 2 randomized dose-finding trial of 60 women at high risk of ovarian hyperstimulation syndrome (OHSS), eggs matured in 95%; per embryo transfer, clinical pregnancy was 53% and live birth 45%, and no woman developed moderate, severe or critical OHSS. Neither study compared kisspeptin with a standard trigger, both were run by the same research group, and these were specialist-controlled single doses during IVF, not use at home.

Effect size
Egg maturation in 95% of high-risk women; live birth 45% per transfer (no standard-trigger comparison group)
Time to effect
Eggs collected 36 hours after the injection
Best fit
Women undergoing IVF at high risk of OHSS, within a research program
Less likely
Anyone trying to conceive outside an IVF clinic; men

Bottom line: A promising research approach for one step of IVF, not a fertility product for home use.

brain responses to sexual cues in low sexual desire (HSDD)

Biomarker support
Limited Evidence

Two randomized, double-blind, placebo-controlled crossover trials gave a single 75-minute intravenous infusion of kisspeptin-54. In 32 premenopausal women with hypoactive sexual desire disorder (mean age 29), it changed activity in brain areas involved in sexual and attraction processing on MRI and was well tolerated, with no reported side effects. In 32 men with HSDD (mean age 38), it changed brain activity in the sexual-processing network compared with placebo, increased penile tumescence (swelling) in response to sexual videos by up to 56% more than placebo, and raised a score for happiness about sex (mean difference 0.63 points); these were secondary results. These were single infusions in a scanner, measuring brain signals and lab responses; whether repeated doses improve desire or sexual satisfaction in daily life has not been tested.

Effect size
Changes in brain activity on MRI; penile tumescence up to 56% more than placebo during one infusion (men)
Time to effect
During a single infusion
Best fit
Research participants with HSDD
Less likely
People seeking a libido treatment now; repeated or at-home use was not studied

Bottom line: One infusion changed brain and arousal measures in a lab; it is not a proven libido treatment.

How it works

Kisspeptin acts on its receptor (G protein-coupled receptor 54) to stimulate the release of GnRH, the brain's master signal for reproduction. GnRH tells the pituitary gland to release LH and FSH, which act on the testes and ovaries. In healthy men, a single intravenous dose of kisspeptin-10 raised LH within 30 minutes, and longer infusions raised testosterone. Timing matters more than amount. The body responds to pulses: when women with hypothalamic amenorrhea had kisspeptin-54 injections twice a day for 2 weeks, the hormone response faded (desensitization). A long-acting kisspeptin-type drug given continuously (TAK-448) had the opposite effect: in healthy men aged 50 or older, a 14-day infusion at doses above 0.1 mg a day pushed testosterone down to castration levels by day 8. In a 2026 study in healthy men, LH and FSH fell back to placebo levels during a continuous 5-day infusion, while daily 8-hour infusions followed by 16-hour breaks kept them raised for 12 days.

How to take it

1. Typical dose
There is no approved or established dose. In research studies, kisspeptin-10 was given into a vein as single doses of 0.01 to 3.0 micrograms per kg, or as infusions; kisspeptin-54 was given as a single injection under the skin (1.6 to 12.8 nmol/kg) to trigger egg maturation in IVF, and as a 75-minute infusion (1 nmol/kg per hour) in sexual desire studies. These are studied doses under supervision, not recommendations.
2. Higher studied dose
In healthy men, an intravenous dose of 3 micrograms per kg of kisspeptin-10 raised LH less than 1 microgram per kg did, so higher doses were not more effective.
3. Timing
Studies used single doses, short infusions, or daily 8-hour infusions with 16-hour breaks; twice-daily injections caused the response to fade within 2 weeks.
4. With food
Not studied; it is not taken by mouth in published trials.
5. Split dosing
Not established.
6. How long to try
Published human studies were short: from a single dose, to 12 days of daily infusions, 2 weeks of twice-daily injections (when the effect faded), and 8 weeks of twice-weekly injections in women with hypothalamic amenorrhea. There are no long-term data.

What to track

If you are in a trial: the hormone tests and visits the study team sets
Any change in libido, erections, periods or mood, which can signal that your hormone system has been switched on or suppressed
Injection-site redness, swelling or signs of infection, a known risk of injected products of unknown quality

Bottom line: No approved dose exists; outside a trial there is no safe, verified way to use it.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

In the published short studies, kisspeptin was generally well tolerated; the 2022 trial in women with low sexual desire reported no side effectsIn a phase 1 study of a kisspeptin-type drug (TAK-448), mild to moderate adverse events occurred in 26% of healthy menInjection-site reactions are possible with any injected peptide

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Kisspeptin has not been studied as a medicine during pregnancy or breastfeeding. In IVF research it was given once, before egg collection, under specialist care, not during pregnancy. Because it acts directly on reproductive hormones, ask your doctor before any use if you are pregnant, breastfeeding or trying to conceive.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

There is no FDA-approved kisspeptin product, so no label can show FDA approval
The legitimate way to receive kisspeptin today is through a registered clinical trial listed on ClinicalTrials.gov, run by a hospital or university with ethics approval

Be skeptical of…

"Natural testosterone booster": the rise lasts hours, fades with repeated dosing, and a continuous kisspeptin-type drug suppressed testosterone
"Fertility peptide" for home use: the IVF studies used a single, timed dose under specialist monitoring
"Libido peptide": studies measured brain scans and lab arousal during one infusion, not desire in daily life
"For research use only" or "not for human consumption" vials sold to consumers: unapproved and unverified
"FDA-approved" or "pharmaceutical grade" kisspeptin: no product is FDA-approved, and FDA lists kisspeptin-10 as a compounding substance that may present significant safety risks
"No side effects" or "safe long term": there are no long-term human data

Frequently asked questions

Is kisspeptin FDA-approved?⌄

No. No kisspeptin product is approved by FDA for any use. It is a research compound studied in universities, mostly as infusions into a vein given under supervision.

Can a pharmacy compound kisspeptin-10 for me?⌄

FDA has listed kisspeptin-10 in category 2 under its interim policy for pharmacy compounding since September 29, 2023, which is its group of bulk substances that may present significant safety risks. FDA says it has no or only limited safety information on the proposed routes and is concerned about immune reactions and impurities. It remained in that category on FDA's list updated May 14, 2026.

Will kisspeptin raise my testosterone?⌄

For a few hours, in research studies, yes: LH and testosterone rose after doses into a vein or under the skin. But repeated twice-daily injections made the response fade, and a continuous kisspeptin-type drug pushed testosterone down to castration levels. No study has shown symptom benefits in men with low testosterone. Talk with your doctor about approved options.

Does kisspeptin help with fertility or IVF?⌄

In small studies at one London IVF clinic, a single injection of kisspeptin-54 matured eggs, and some women went on to have babies, including women at high risk of ovarian hyperstimulation. These studies did not compare it with the standard trigger shot, and it is not available as an approved product.

Does it work for low sexual desire?⌄

One infusion changed brain responses to sexual images in women and men with hypoactive sexual desire disorder, and increased penile tumescence in men during the test. Whether it improves desire in daily life is unknown. An approved medicine for this condition in premenopausal women, bremelanotide (Vyleesi), works in a different way; ask your doctor about it.

Can I take kisspeptin with my supplements?⌄

No interaction studies with supplements or other medicines exist, so nothing is known about combining it with them. A doctor or pharmacist should check your full list.

References by claim

LH and testosterone levels in healthy men

George et al., 2011 · PMC (2011) link

Yeung et al., 2026 · PubMed (2026) link

triggering egg maturation during IVF

Jayasena et al., 2014 · PMC (2014) link

Abbara et al., 2015 · PMC (2015) link

brain responses to sexual cues in low sexual desire (HSDD)

Thurston et al., 2022 · PMC (2022) link

Mills et al., 2023 · PMC (2023) link

Safety

FDA: Certain bulk drug substances for use in compounding that may present significant safety risks · FDA link

FDA: Bulk drug substances nominated for use in compounding under section 503A (updated May 14, 2026) · FDA link

Jayasena et al., 2009 · PubMed (2009) link

MacLean et al., 2014 · PubMed (2014) link

Jayasena et al., 2010 · PubMed (2010) link

FDA: Compounding and the FDA, questions and answers · FDA link

Track Kisspeptin with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 19, 2026·Evidence current as of Nov 19, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.